WEYERHAEUSER ($WY) posted quarterly earnings results on Thursday, July 24th. The company reported earnings of $0.12 per share, beating estimates of $0.11 by $0.01. The company also reported revenue of $1,884,000,000, missing estimates of $1,891,176,933 by $-7,176,933.
You can see Quiver Quantitative's $WY stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
WEYERHAEUSER Hedge Fund Activity
We have seen 404 institutional investors add shares of WEYERHAEUSER stock to their portfolio, and 439 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- INVESCO LTD. removed 3,901,947 shares (-28.9%) from their portfolio in Q1 2025, for an estimated $114,249,008
- MILLENNIUM MANAGEMENT LLC added 3,027,823 shares (+2952.7%) to their portfolio in Q1 2025, for an estimated $88,654,657
- BANK OF NEW YORK MELLON CORP added 2,833,288 shares (+63.9%) to their portfolio in Q1 2025, for an estimated $82,958,672
- PRICE T ROWE ASSOCIATES INC /MD/ removed 2,003,641 shares (-4.8%) from their portfolio in Q1 2025, for an estimated $58,666,608
- BALYASNY ASSET MANAGEMENT L.P. added 1,968,429 shares (+94.4%) to their portfolio in Q1 2025, for an estimated $57,635,601
- CLEAN ENERGY TRANSITION LLP added 1,893,056 shares (+inf%) to their portfolio in Q1 2025, for an estimated $55,428,679
- ADAGE CAPITAL PARTNERS GP, L.L.C. added 1,812,200 shares (+inf%) to their portfolio in Q1 2025, for an estimated $53,061,216
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
WEYERHAEUSER Government Contracts
We have seen $19,000 of award payments to $WY over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
WEYERHAEUSER Congressional Stock Trading
Members of Congress have traded $WY stock 5 times in the past 6 months. Of those trades, 2 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $WY stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 02/25 and 1 sale worth up to $15,000 on 05/15.
- REPRESENTATIVE JEFFERSON SHREVE has traded it 2 times. They made 1 purchase worth up to $50,000 on 03/13 and 1 sale worth up to $50,000 on 04/11.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 04/01.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
WEYERHAEUSER Analyst Ratings
Wall Street analysts have issued reports on $WY in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- DA Davidson issued a "Buy" rating on 07/22/2025
- JP Morgan issued a "Overweight" rating on 07/01/2025
- Citigroup issued a "Buy" rating on 06/03/2025
- CIBC issued a "Outperformer" rating on 04/22/2025
- RBC Capital issued a "Outperform" rating on 02/03/2025
To track analyst ratings and price targets for WEYERHAEUSER, check out Quiver Quantitative's $WY forecast page.
WEYERHAEUSER Price Targets
Multiple analysts have issued price targets for $WY recently. We have seen 6 analysts offer price targets for $WY in the last 6 months, with a median target of $31.5.
Here are some recent targets:
- Kurt Yinger from DA Davidson set a target price of $35.0 on 07/22/2025
- Hong Zhang from JP Morgan set a target price of $30.0 on 07/01/2025
- Anthony Pettinari from Citigroup set a target price of $31.0 on 06/03/2025
- Michael Roxland from Truist Securities set a target price of $30.0 on 04/22/2025
- Hamir Patel from CIBC set a target price of $32.0 on 04/22/2025
- Matthew McKellar from RBC Capital set a target price of $36.0 on 02/03/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.